title: [Protective effect of Ligustrazine preconditioning on hepatic energy metabolism in ischemia/reperfusion injury of rat].
abstract: OBJECTIVE
  Objective to investigate the protective effects of Ligustrazine preconditioning against hepatic ischemia/reperfusion injury (IRI) in rats.
  
  
  METHODS
  Fifty male Wistar rats were randomly allocated into 3 groups: sham operation group, in which animals underwent laparotomy, experimental group and control group in which were treated with 70% IRI of the liver, especially, the animals in experimental group was given intraperitoneal injection of 2 mL Ligustrazine per day for 3 days before operation. After the operation, liver tissues were harvested at 1 h, 6 h, 24 h and 72 h for the study of histomorphological change, the respiratory control ratio (RCR) and phosphorus: oxygen ratio (P/O) of hepatocytes mitochondria, and the contents of adenosine triphosphate (ATP) of liver tissue.
  
  
  RESULTS
  (1) The damage hepatic tissue in experimental group was slighter than that in control group at each corresponding time-point after operation. (2) The RCR and P/O ratio at each corresponding time-point were higher in experimental group than those in control group (P < 0.05), and all of the two groups recovered after 72 h. (3) The ATP concentration in experimental group also was higher than that in control group at each corresponding time-point, and recovered faster than control group.
  
  
  CONCLUSIONS
  The current results show that Ligustrazine preconditioning may improve energy metabolism of rat liver in ischemia reperfusion injury.
authors.affiliation: Department of General Surgery, Chengdu General Military Hospital, Chengdu 610083, China.
authors.forename: Zhu-Lin
authors.initials: ZL
authors.lastname: Luo
authors.forename: Fu-Zhou
authors.initials: FZ
authors.lastname: Tian
authors.forename: Li-Jun
authors.initials: LJ
authors.lastname: Tang
authors.forename: Tao
authors.initials: T
authors.lastname: Wang
authors.forename: Jian-Dong
authors.initials: JD
authors.lastname: Ren
authors.forename: Hong-Tao
authors.initials: HT
authors.lastname: Yan
authors.forename: Zhu
authors.initials: Z
authors.lastname: Huang
authors.forename: Hua
authors.initials: H
authors.lastname: Wan
mesh_terms: D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects*; D019194:Ischemic Preconditioning / Q000379:methods*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000517:prevention & control*
chemical_list: D011719:Pyrazines; C017953:tetramethylpyrazine